Bank of America
COLL icon

Bank of America’s Collegium Pharmaceutical COLL Stock Holding History

Bank of America’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-50,000
Closed -$1.19M – 7284
2018
Q2 		$1.19M Buy
50,000
+14,100
+39% +$347K ﹤0.01% 4359
2018
Q1 		$917K Buy
+35,900
New +$855K ﹤0.01% 4444

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of America's COLL Position: Q1 2026 in Review

Bank of America increased its Collegium Pharmaceutical (COLL) stake by 52% in Q1 2026, buying an estimated $4.34M and bringing the position to 297,847 shares worth $9.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2972.

Bank of America first reported a position in COLL in Q2 2015 and has held it in 44 quarters since. The position peaked at $15.2M in Q2 2025. 267 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Bank of America held 297,847 shares of Collegium Pharmaceutical worth $9.85M as of Q1 2026.
  • Bank of America bought 102,502 Collegium Pharmaceutical shares in Q1 2026, an estimated $4.34M.
  • Collegium Pharmaceutical made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2972 holding.
  • Bank of America first reported a position in Collegium Pharmaceutical in Q2 2015 and has held it in 44 quarters since.
  • Bank of America's Collegium Pharmaceutical position peaked at $15.2M in Q2 2025.
  • 267 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.